Empowered Funds’s PTC Therapeutics PTCT Stock Holding History

Empowered Funds’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.63M	Buy	81,271 +23,365	+40%	+$1.69M	0.03%	575
2026 Q1	$3.95M	Sell	57,906 -192,506	-77%	-$13.6M	0.03%	745
2025 Q4	$19M	Buy	250,412 +206,707	+473%	+$15M	0.32%	60
2025 Q3	$2.68M	Buy	43,705 +1,198	+3%	+$62.4K	0.03%	771
2025 Q2	$2.08M	Buy	42,507 +3,279	+8%	+$156K	0.02%	802
2025 Q1	$2M	Buy	+39,228	New	+$1.96M	0.03%	746
2024 Q2	–	Sell	-41,598	Closed	-$1.21M	–	1441
2024 Q1	$1.21M	Buy	+41,598	New	+$1.17M	0.02%	796

Other funds holding PTCT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Empowered Funds's PTCT Position: Q2 2026 in Review

Empowered Funds increased its PTC Therapeutics (PTCT) stake by 40% in Q2 2026, buying an estimated $1.69M and bringing the position to 81,271 shares worth $6.63M. The position accounts for 0.03% of the portfolio, ranked #575.

Empowered Funds first reported a position in PTCT in Q1 2024 and has held it in 7 quarters since. The position peaked at $19M in Q4 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

Empowered Funds held 81,271 shares of PTC Therapeutics worth $6.63M as of Q2 2026.
Empowered Funds bought 23,365 PTC Therapeutics shares in Q2 2026, an estimated $1.69M.
PTC Therapeutics made up 0.03% of Empowered Funds's portfolio in Q2 2026, its #575 holding.
Empowered Funds first reported a position in PTC Therapeutics in Q1 2024 and has held it in 7 quarters since.
Empowered Funds's PTC Therapeutics position peaked at $19M in Q4 2025.
382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.